0 01/07/2023 30/06/2024 2024-06-30 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2023-07-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 12638687 2023-07-01 2024-06-30 12638687 2024-06-30 12638687 2023-06-30 12638687 2022-07-01 2023-06-30 12638687 2023-06-30 12638687 2022-06-30 12638687 bus:RegisteredOffice 2023-07-01 2024-06-30 12638687 bus:LeadAgentIfApplicable 2023-07-01 2024-06-30 12638687 bus:Director1 2023-07-01 2024-06-30 12638687 core:WithinOneYear 2024-06-30 12638687 core:WithinOneYear 2023-06-30 12638687 bus:Micro-entities 2023-07-01 2024-06-30 12638687 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 12638687 bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 12638687 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 12638687 bus:FullAccounts 2023-07-01 2024-06-30
Company registration number: 12638687
LOJ Clinical Research Services Limited
Unaudited filleted financial statements
30 June 2024
LOJ Clinical Research Services Limited
Contents
Directors and other information
Accountants report
Statement of financial position
LOJ Clinical Research Services Limited
Directors and other information
Director L O Johnson
Company number 12638687
Registered office Exchange Building
66 Church Street
Hartlepool
TS24 7DN
Accountants Censis
Exchange Building
66 Church Street
Hartlepool
TS24 7DN
LOJ Clinical Research Services Limited
Chartered accountants report to the director on the preparation of the
unaudited statutory financial statements of LOJ Clinical Research Services Limited
Year ended 30 June 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of LOJ Clinical Research Services Limited for the year ended 30 June 2024 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/members/regulations-standards-and-guidance/.
This report is made solely to the director of LOJ Clinical Research Services Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of LOJ Clinical Research Services Limited and state those matters that we have agreed to state to them, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than LOJ Clinical Research Services Limited and its director as a body for our work or for this report.
It is your duty to ensure that LOJ Clinical Research Services Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of LOJ Clinical Research Services Limited. You consider that LOJ Clinical Research Services Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of LOJ Clinical Research Services Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Censis
Chartered Accountants
Exchange Building
66 Church Street
Hartlepool
TS24 7DN
27 November 2024
LOJ Clinical Research Services Limited
Statement of financial position
30 June 2024
2024 2023
£ £
Fixed assets 658 658
_______ _______
Current assets 2,115 7,463
Creditors: amounts falling due within one year ( 43) ( 43)
_______ _______
Net current assets 2,072 7,420
_______ _______
Total assets less current liabilities 2,730 8,078
Accruals and deferred income ( 821) ( 821)
_______ _______
Net assets 1,909 7,257
_______ _______
Capital and reserves 1,909 7,257
_______ _______
LOJ Clinical Research Services Limited
Year ended 30 June 2024
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The member has not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 27 November 2024 , and are signed on behalf of the board by:
L O Johnson
Director
Company registration number: 12638687
The company is a private company limited by shares, registered in England.